02.1 Oil vs powder

Vitamin K2 MK-7 oil vs powder: carrier, overage and the label

Technical document 02.1 · Reviewed 2026-11-20 · Vitamin K2 MK-7 Oil

On this page
  1. The carrier is the product
  2. Both are 1%, so the fill weight barely moves
  3. The overage is a formula decision
  4. What the label has to declare
  5. The pack and the failure route change
  6. When to choose the oil and when the powder

At 1% MK-7 the oil and the spray-dried powder are close to the same strength, so a switch between them is not a potency upgrade or downgrade. What changes is the body of the product: a lipid that mixes with oils versus a solid that disperses in water, and with it the overage calculation, the ingredient list and the pack.

In one line

The oil and the powder carry the same 1% MK-7, so the switch changes the carrier, the overage arithmetic and the label, not the strength.

The carrier is the product

The carrier is the larger part of both products. At 1% MK-7, roughly 99 g of every 100 g is carrier, and that carrier is what the process actually handles. In the oil it is a food-grade lipid named on the specification; in the powder it is starch or gum arabic, named on the powder certificate. Neither is a neutral filler: each one decides the allergen statement, the way the product mixes and the pack that protects it.

The oil's lipid carrier is miscible with other oils, which is what a softgel fill or an oil blend needs. It is not water-dispersible, and a claim to the contrary needs an emulsified oil with its own data. The powder's solid carrier gives flow, blendability and, with gum arabic, water dispersibility, which is what a tablet, hard capsule or stick pack needs. The allergen question follows the carrier, so the oil and the powder can carry different declarations even when the MK-7 is identical.

Both are 1%, so the fill weight barely moves

The two forms are unusually close in concentration: oil 1.0–1.1%, powder 0.9–1.1%. A 100 µg dose is about 9–11 mg of either, so the fill weight does not change much. The table shows the edges.

The same MK-7 dose in oil and in 1% powder
Label dose (µg MK-7)Oil at 1.0% (mg)Oil at 1.1% (mg)Powder at 0.9% (mg)Powder at 1.1% (mg)
505.04.55.64.5
10010.09.111.19.1
20020.018.222.218.2
50050.045.555.645.5

These are release minimums, before overage and before the rest of the fill. A softgel fill is far larger than 10 mg, so the oil is diluted into the fill. A capsule built on the powder uses 10–11 mg as one part of a larger fill and brings the solid carrier with it. Same dose, same order of mass, different handling.

The overage is a formula decision

The assay range is not an overage. A formula written at 1.0% and a lot that assays at 1.1% already carry about 10% more MK-7 than the calculation. If the formulator then adds 10% overage for shelf-life loss, the batch leaves with roughly 21% above the label target. The two effects are separate and both belong in the same calculation.

The overage itself is set from the stability curve for the finished form. Oil and powder fail by different routes: the oil's carrier oxidises and its all-trans share can fall, while the powder picks up moisture and loses potency under light. A number taken from the other form's stability file is not transferable. Process loss is a third input: oil clings to tanks and lines, powder dusts and blends unevenly, and the overage has to cover the route that actually applies.

None of this repairs a bad pack. An overage cannot compensate for a bottle that admits light or a pouch that admits moisture.

What the label has to declare

The label declares the vitamin, not the 1% figure. In the EU, the novel-food designation is “Menaquinone” or “Vitamin K2”; the ingredient list names what is present, and the amount is stated per daily portion in micrograms against the 75 µg reference intake. In the US, the Supplement Facts panel reports vitamin K (as menaquinone-7) in micrograms and as a percentage of the 120 µg Daily Value. The carrier and any antioxidant go in the ingredients list in both markets.

Label elements for the two forms
ElementEUUS
Nutrient nameMenaquinone or vitamin K2Vitamin K (as menaquinone-7)
Amount and referenceµg per daily portion; % of 75 µg NRVµg per serving; % of 120 µg Daily Value
CarrierIngredient list; allergen declaration if the carrier requires oneIngredient list; allergen declaration if the carrier requires one
Dispersion wordingA water-dispersible claim needs supporting dataA water-dispersible claim needs supporting data

The oil cannot support a water-dispersible statement; the powder can, within the limits of its carrier. A label written for one form is not valid for the other even when the microgram figure matches. The concentration stays on the specification, and “all-trans” stays a specification term rather than a claim.

The pack and the failure route change

Pack follows failure route. The oil goes into amber glass because light and oxygen are what attack it; the powder goes into a foil pouch because moisture and light are what attack it. A softgel adds an opaque shell and a low-oxygen fill space; a stick pack adds a foil barrier and a sealed seam. Changing the pack means generating new stability data, not just buying a different container.

At the bench, handle them differently. The oil is mixed before weighing and warmed only gently if it is viscous, and the bottle is closed between uses. The powder is kept dry, resealed and out of humid air. Both dislike heat, and neither belongs in a hot loading bay. The oil stability page carries the protocol.

When to choose the oil and when the powder

Pick the oil when the fill is a lipid: a softgel, an oil blend, a lipid-based delivery system. Pick the powder when the fill is dry: a tablet, a hard capsule, a stick pack, a dry blend. Pick neither when the dose is large and the fill is small; an isolated concentrate is the better physical fit.

The switch is a reformulation. It needs a new specification, a new label and a new stability file, and it belongs in the change-control process. The oil product page carries the oil specification; the spray-dried powder page covers the solid grade; the grades page compares them with the other MK-7 forms; the compliance page covers the market file; the methods index explains the assays; the quality page describes release.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation